Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.14
(0.0%)
CNY 8.14
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 162.89 Million CNY | 0.81% |
| 2022 | 161.58 Million CNY | -5.39% |
| 2021 | 170.79 Million CNY | 3.42% |
| 2020 | 165.14 Million CNY | 25.69% |
| 2019 | 131.39 Million CNY | 35.58% |
| 2018 | 96.91 Million CNY | 39.97% |
| 2017 | 69.23 Million CNY | 1.57% |
| 2016 | 68.16 Million CNY | 18.13% |
| 2015 | 57.7 Million CNY | 7.15% |
| 2014 | 53.85 Million CNY | 47.55% |
| 2013 | 36.49 Million CNY | 24.56% |
| 2012 | 29.3 Million CNY | 119.47% |
| 2011 | 13.35 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 40.6 Million CNY | -7.25% |
| 2024 Q1 | 32.68 Million CNY | -33.23% |
| 2024 Q2 | 43.78 Million CNY | 33.95% |
| 2023 Q3 | 23.34 Million CNY | -54.08% |
| 2023 Q4 | 48.94 Million CNY | 109.65% |
| 2023 FY | 162.89 Million CNY | 0.81% |
| 2023 Q1 | 39.74 Million CNY | -32.69% |
| 2023 Q2 | 50.84 Million CNY | 27.92% |
| 2022 FY | 161.58 Million CNY | -5.39% |
| 2022 Q3 | 37.57 Million CNY | 4.28% |
| 2022 Q4 | 59.05 Million CNY | 57.15% |
| 2022 Q2 | 36.03 Million CNY | 24.6% |
| 2022 Q1 | 28.92 Million CNY | -45.12% |
| 2021 Q2 | 32.5 Million CNY | -29.08% |
| 2021 Q1 | 45.83 Million CNY | -26.55% |
| 2021 Q3 | 39.75 Million CNY | 22.28% |
| 2021 Q4 | 52.69 Million CNY | 32.57% |
| 2021 FY | 170.79 Million CNY | 3.42% |
| 2020 Q1 | 24.49 Million CNY | -24.0% |
| 2020 FY | 165.14 Million CNY | 25.69% |
| 2020 Q3 | 39.47 Million CNY | 1.85% |
| 2020 Q4 | 62.41 Million CNY | 58.09% |
| 2020 Q2 | 38.75 Million CNY | 58.25% |
| 2019 Q1 | 24.12 Million CNY | -6.26% |
| 2019 FY | 131.39 Million CNY | 35.58% |
| 2019 Q4 | 32.22 Million CNY | 4.32% |
| 2019 Q3 | 30.89 Million CNY | -30.03% |
| 2019 Q2 | 44.15 Million CNY | 83.03% |
| 2018 Q1 | 17.82 Million CNY | -24.53% |
| 2018 Q2 | 27.18 Million CNY | 52.5% |
| 2018 Q4 | 25.73 Million CNY | -1.66% |
| 2018 Q3 | 26.16 Million CNY | -3.75% |
| 2018 FY | 96.91 Million CNY | 39.97% |
| 2017 Q4 | 23.62 Million CNY | 51.71% |
| 2017 Q1 | 14.17 Million CNY | -38.45% |
| 2017 Q2 | 15.87 Million CNY | 11.98% |
| 2017 Q3 | 15.56 Million CNY | -1.91% |
| 2017 FY | 69.23 Million CNY | 1.57% |
| 2016 Q2 | 21.94 Million CNY | 91.57% |
| 2016 Q4 | 23.02 Million CNY | 96.1% |
| 2016 Q3 | 11.74 Million CNY | -46.48% |
| 2016 Q1 | 11.45 Million CNY | 0.0% |
| 2016 FY | 68.16 Million CNY | 18.13% |
| 2015 FY | 57.7 Million CNY | 7.15% |
| 2014 Q2 | 11.07 Million CNY | 0.0% |
| 2014 FY | 53.85 Million CNY | 47.55% |
| 2014 Q1 | 11.07 Million CNY | 0.0% |
| 2013 FY | 36.49 Million CNY | 24.56% |
| 2012 FY | 29.3 Million CNY | 119.47% |
| 2011 FY | 13.35 Million CNY | 0.0% |